• Australia & New Zealand

    Since 1993, Quintiles Australia and New Zealand have provided fully integrated services for Phase II-IV clinical studies to the pharmaceutical industry. These locations are part of our infrastructure that enables the transfer of best practices around the globe.
  • Australia and New Zealand Perspectives

  • Quintiles

    Middle East Oncology Capabilities

    Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates.

  • Quintiles

    Quintiles, HKPI, Ramco Announce Joint Venture in Egypt

     September 29, 2010 - Quintiles, Health Kare Pharma International (HKPI), and Ramco Import and Export announced the formation of a joint venture to provide commercialization services in Egypt.

  • Quintiles
    Fusce ultrices purus in sapien convallis malesuada. Maecenas dignissim egestas auctor Prof. Jae Lee